Beyond Tumor Recapitulation: A Multidimensional Framework for Cancer Organoid Fidelity

Patient-derived cancer organoids (PDOs) are increasingly used to investigate tumor biology, treatment response, and precision oncology, yet their correspondence to the tumors from which they originate is often summarized using global terms such as “recapitulation” or “fidelity.” Such terminology obscures the fact that tumor–organoid correspondence may differ across genomic, clonal, cellular, spatial, metabolic, organelle, temporal, and therapeutic dimensions. Here, cancer organoid fidelity is reframed as a reference-specific and dimension-specific property organized across three analytically distinguishable but biologically interdependent domains: composition, state, and function. We examine how spatial sampling, tissue processing, culture establishment, matrix and medium composition, oxygen and nutrient availability, passage, and multicellular reconstruction can preserve selected tumor features while reshaping others. This distinction is particularly important for metabolism, mitochondrial and lysosomal function, autophagy and mitophagy, ferroptosis, treatment adaptation, and acquired resistance, for which similar phenotypes may arise through different upstream mechanisms. We introduce Culture-Induced State Distortion (CISD) to describe reproducible culture-associated states that differ from the parental tumor reference and propose the Organoid Fidelity Mapping Framework (OFMF) to classify dimension-specific evidence and define the limits of biological inference. Applying the framework to published colorectal cancer and glioblastoma organoid studies illustrates how validated features can coexist with unassessed dimensions. We also consider how reference availability, experimental resources, and clinical feasibility constrain the assessment and interpretation of fidelity. This framework supports question-driven selection of the minimum sufficient model rather than equating increasing experimental complexity with increasing biological fidelity.

Authors

Institutions

Publication Details

Journal
Organoids
Published
2026-10-15
DOI
https://doi.org/10.3390/organoids5040036
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Tumor Recapitulation: A Multidimensional Framework for Cancer Organoid Fidelity

Ayhan Bılır, Berna Yıldırım, Mete Hakan Karalök
Organoids
Cancer Cells and Metastasis
article

Beyond Tumor Recapitulation: A Multidimensional Framework for Cancer Organoid Fidelity

Ayhan Bılır, Berna Yıldırım, Mete Hakan Karalök
article en

Abstract

Patient-derived cancer organoids (PDOs) are increasingly used to investigate tumor biology, treatment response, and precision oncology, yet their correspondence to the tumors from which they originate is often summarized using global terms such as “recapitulation” or “fidelity.” Such terminology obscures the fact that tumor–organoid correspondence may differ across genomic, clonal, cellular, spatial, metabolic, organelle, temporal, and therapeutic dimensions. Here, cancer organoid fidelity is reframed as a reference-specific and dimension-specific property organized across three analytically distinguishable but biologically interdependent domains: composition, state, and function. We examine how spatial sampling, tissue processing, culture establishment, matrix and medium composition, oxygen and nutrient availability, passage, and multicellular reconstruction can preserve selected tumor features while reshaping others. This distinction is particularly important for metabolism, mitochondrial and lysosomal function, autophagy and mitophagy, ferroptosis, treatment adaptation, and acquired resistance, for which similar phenotypes may arise through different upstream mechanisms. We introduce Culture-Induced State Distortion (CISD) to describe reproducible culture-associated states that differ from the parental tumor reference and propose the Organoid Fidelity Mapping Framework (OFMF) to classify dimension-specific evidence and define the limits of biological inference. Applying the framework to published colorectal cancer and glioblastoma organoid studies illustrates how validated features can coexist with unassessed dimensions. We also consider how reference availability, experimental resources, and clinical feasibility constrain the assessment and interpretation of fidelity. This framework supports question-driven selection of the minimum sufficient model rather than equating increasing experimental complexity with increasing biological fidelity.

OrganoidsVol. 5(4)
Atlas Üniversitesi
Good health and well-being
Openalex Percentile: Top 17%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.